TScan Therapeutics Inc Sustainability Reports
TScan Therapeutics, Inc. is a clinical-stage biotechnology company that develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of cancer.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG00PH1N025
2 reports from 2023 to 2024